In this Monday, July 15, 2013, photo, New York Yankees third baseman Alex Rodriguez warms up before batting against the Reading Fightin Phils, during his rehab appearance with the Trenton Thunder in Reading, Pa.
Credit: AP
© 2024 Blaze Media LLC. All rights reserved.
AP Source: Baseball Exec Says Clinic's Alleged PED Sales to Minors Not a League Concern
October 19, 2013
MLB was interested only in possible criminal activity involving players.
Story by the Associated Press; curated by Dave Urbanski
NEW YORK (AP) — A person familiar with the grievance hearing of New York Yankees' Alex Rodriguez tells The Associated Press that Major League Baseball's No. 2 executive testified this week that the league wasn't concerned if the head of a Florida clinic distributed performance-enhancing drugs to minors.
New York Yankees third baseman Alex Rodriguez (Credit: AP)
Rather MLB's sole interest was the relationship Biogenesis of America founder Anthony Bosch had with players under investigation, the source said. The source spoke to the AP on condition of anonymity because the testimony is confidential.
MLB chief operating officer Rob Manfred was asked by Rodriguez's lawyers about documents indicating that Bosch had given PEDs to high school students. Manfred said he assumed, based on documents in MLB's possession and media reports, Bosch had distributed illegal substances to minors, but he never asked Bosch about it.
Manfred added that MLB was interested only in possible criminal activity involving players, the person familiar with the hearing said.
--
[related]
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
Sr. Editor, News
Dave Urbanski is a senior editor for Blaze News.
DaveVUrbanski
more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.